{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:02:14Z","timestamp":1785722534982,"version":"3.56.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clinthera.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T21:47:00Z","timestamp":1454708820000},"page":"670-675","source":"Crossref","is-referenced-by-count":14,"title":["Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases"],"prefix":"10.1016","volume":"38","author":[{"given":"Rosy","family":"N\u2019gbo N\u2019gbo Ikazabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mostosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Quivron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Delberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoutar","family":"El Hafsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas P.","family":"Lysandropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.01.010_bib1","first-page":"CD007621","article-title":"Natalizumab for relapsing remitting multiple sclerosis","volume":"10","author":"Pucci","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2016.01.010_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2016.01.010_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2016.01.010_bib4","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1212\/WNL.0b013e3182768983","article-title":"Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?","volume":"79","author":"Antoniol","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2016.01.010_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1586\/14737175.2014.874947","article-title":"We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?","volume":"14","author":"Fragoso","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.clinthera.2016.01.010_bib6","unstructured":"EMA EPAR product information. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000603\/WC500044686.pdf. Accessed March 25, 2015."},{"key":"10.1016\/j.clinthera.2016.01.010_bib7","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.0b013e31821e7c8a","article-title":"Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis","volume":"76","author":"O\u05f3Connor","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2016.01.010_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneurol.2010.257","article-title":"Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy","volume":"68","author":"Miravalle","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinthera.2016.01.010_bib9","unstructured":"Biogen Medical information website. https:\/\/medinfo.biogenidec.com\/medinfo. Accessed August 30, 2014."},{"key":"10.1016\/j.clinthera.2016.01.010_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acn3.114","article-title":"Outcome and survival of asymptomatic PML in natalizumab-treated MS patients","volume":"1","author":"Dong-Si","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.clinthera.2016.01.010_bib11","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1212\/WNL.0b013e318275979d","article-title":"Lethal multiple sclerosis relapse after natalizumab withdrawal","volume":"79","author":"Rigau","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2016.01.010_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jnnp-2014-308154","article-title":"Minimal supportive treatment in natalizumab-related PML in a MS patient","volume":"86","author":"Lalive","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T17:56:08Z","timestamp":1537034168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0149291816000230"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.01.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}